Background. There is limited information available regarding the management of
multisystem inflammatory syndrome in children (MIS‐C) associated with SARS‐CoV‐2. We …

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition characterized
by excessive inflammation that can arise as a complication of SARS-CoV-2 infection in …

Objective To determine the outcomes in children with MIS-C receiving different
immunomodulatory treatment. Methods In this multicentric, retrospective cohort study, data …

Background Multisystem inflammatory syndrome in children (MIS-C), a relatively uncommon
but severe pediatric complication, is associated with coronavirus disease 2019 (COVID-19) …

With the increased spread of severe acute respiratory syndrome coronavirus 2 infection,
more patients with multisystem inflammatory syndrome in children (MIS-C) are being …

In late 2019, SARS-CoV-2 was detected in China and spread worldwide. In rare cases,
children who were infected with COVID-19 may develop multisystem inflammatory syndrome …

PURPOSE: The pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has infected over 43 million people resulting in over 1 million deaths …

Background Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory
condition associated with SARS-CoV-2 infection, has emerged as a serious illness in …

Abstract Purpose of Review Different treatment approaches have been described for the
management of COVID-19-related multisystem inflammatory syndrome in children (MIS-C) …

Objective: The purpose of this study was to map and describe the studies that have
investigated therapeutic alternatives for the management of paediatric multisystem …